U.S. Stocks to Watch: Novo Nordisk, Eli Lilly, Oracle, Micron, Zions Bancorp, American Express, and More

Dow Jones
Yesterday

US stock futures fell Friday as worries about regional bank loans weighed on sentiment and investors feared a bumpy road ahead for credit markets.

These stocks were poised to make moves Friday:

U.S.-listed shares of Novo Nordisk fell 4.6% after President Donald Trump suggested the price of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy could be reduced to $150 a month. The current list price for the medicines is around $1,000. Trump's comments came amid a wider push for lower medicine prices for Americans. Shares of Eli Lilly, which makes rival drugs Mounjaro and Zepbound, fell 4.4% in premarket trading.

Oracle fell 3.3% in premarket trading after shares of the enterprise software company closed up 3.1% in the previous session. The move higher Thursday followed the stock whipsawing throughout the trading session as Oracle discussed the outlook for the next five years and weighed in on cloud margins. Following a report by the Information last week saying that the profit margins at Oracle's cloud server-rental business were surprisingly low, the company attributed the low number to the rapid expansion of data-center expenses before customer contracts go live.

Micron plans to stop supplying server chips to data centres in China after the business failed to recover from a 2023 government ban on its products in critical Chinese infrastructure, Reuters reported. The shares dropped 2.7% in premarket trading.

Zions Bancorp fell 1.1% after a 13% drop Thursday. The regional bank said late Wednesday it recently became aware of "legal actions initiated by several banks and other lenders" against parties affiliated with two of its commercial and industrial borrowers. The bank said it was taking a $50 million charge-off as part of a $60 million provision related to the loans.

Regional bank peer Western Alliance Bancorp. fell 2.3%, extending losses after closing down 11% on Thursday. The bank said it filed a lawsuit in August against one of its borrowers, alleging the company committed fraud.

Hewlett Packard Enterprise extended losses in premarket trading, falling 2%. Shares closed down 10% Thursday. The move lower came after the server and cloud company issued weaker-than-expected guidance for fiscal 2026.

Shares of Interactive Brokers fell 3.8% even as the electronic brokerage's third-quarter earnings beat analysts' expectations. Earnings of 59 cents a share topped Wall Street forecasts of 54 cents. Earnings were helped by higher trading volumes as the stock market rally has enticed investors to open more accounts and use more margin.

CSX, the railroad company, posted third-quarter adjusted earnings of 44 cents on revenue of $3.59 billion, beating expectations for earnings of 42 cents on revenue of $3.57 billion. The stock rose 3.8%.

Kenvue closed Thursday as the worst-performing stock in the S&P 500, declining 13% as a lawsuit filed Tuesday at the U.K. High Court representing more than 3,000 people alleged Johnson & Johnson, which spun off Kenvue in 2023, knowingly sold baby powder that was contaminated with asbestos, a carcinogen. The lawsuit targeted both Johnson & Johnson and Kenvue U.K. Ltd., a subsidiary. Kenvue shares rose 0.5% in premarket trading, while J&J edged up 0.2%.

Earnings reports are expected Friday from American Express, Truist Financial, SLB, State Street, Fifth Third Bancorp, Comerica, Ally Financial, and Autoliv.

American Express fell in 0.5% in premarket trading ahead of third-quarter earnings from the credit-card giant.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10